chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Low grade fever 100-101 x 4 days following immun occasional loosestools; 5th day 22MAY91 temp 103.2 called MD advised APAP & come to office 23MAY91; Advised to observe, give APAP; Says it was rxn to immun;
shingles; This is a spontaneous report from a non-contactable consumer (wife). A 74-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown) via an unspecified route of administration in upper left arm on 24May2021 at 16:40 as 1st single dose for COVID-19 immunisation. The patient medical history include chickenpox. The patient concomitant medication includes apixaban (ELIQUIS) taken for unspecified indication in May probably a couple of months and supplements. Patient had no history of all previous immunization with the Pfizer vaccine considered as suspect. Patient had no other vaccinations within four weeks prior to the first administration date of the suspect vaccine. Patient had no adverse event prior to vaccine. On an unspecified date in May2021, the patient got shingles which was triggered by the shot. The patient was diagnosed with shingles following receiving the vaccine, confirmed as Pfizer Covid-19 Vaccine. It happened a few days later, the symptoms started about the 3rd day after the vaccine was given and patient had no idea, when he went into the Emergency facility that he had shingles. Patient thought it might be something else and was highly surprised. Patient was still experiencing it, it was about the same and he was miserable. Patient did go to the Emergency area at the hospital and they gave him prescriptions and checked him over but they did not know right away he had shingles. They found it before he left and gave patient something for pain. The patient came home, and was not admitted. The reporter informed that the patient had chicken pox and that was why it was able to be triggered in him with the shingles. People who had shingles had the chicken pox. Patient was due for second dose. The event required patient to visit emergency room. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
rash around eyes, back, stomach, neck (2 wks p/shots) coughing, coryza, (no fever) diarrhea x 4 days;
Rash on upper torso, noticed it on Monday evening. It spread a little to above panty line the next day. It's not particularly itching but some.; Rash on upper torso, noticed it on Monday evening. It spread a little to above panty line the next day. It's not particularly itching but some.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP-6955) via an unspecified route of administration in the left arm on 15Apr2021 at 11:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had received the vaccine (unspecified) within four weeks prior to the vaccination. Concomitant medications included fish oil (MANUFACTURER UNKNOWN) and multivitamins (MANUFACTURER UNKNOWN), both were taken for unspecified indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, the patient experienced rash on upper torso, noticed it on Monday evening. It spread a little to above panty line the next day. It was not particularly itching but some. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash on upper torso, noticed it on monday evening, it spread a little to above panty line the next day, it was not particularly itching but some were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient developed an oval, red, raised skin rash near vaccination site consistent with an delayed allergic skin reaction.
Information has been received from a physician concerning a 27 year old female with no known drug allergies and no pertinent medical history who on 15-Sep-2005 was vaccinated (the 1st shot) and 13-Oct-2005 (the 2nd shot) with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (the lot number not reported).  There was no concomitant medication. the first vaccine was no problem. After the second vaccination, on 13-Oct-2005, the patient developed fatigue and warmth.  On 14-Oct-2005 there were nodules, erythema, rash and itching around the injection site.  Then on 15-Oct-2005  her menstrual period began normally and on 16-Oct-2005 she began to develop numbness and paresthesia on her outer vagina and perianal region.  The patient reported that her bowel remained movements felt different and the sensation spread down to her gluteal region.  The vaginal area had remained the same but the gluteal/anal region symptoms had progressed and become worse.  The patient sought unspecified medical attention: no laboratory or diagnostic tests were performed.  It was reported that the patient had not recovered.  There was no product quality complaint involved.
Friday woke up very tired and very sore joints (like i had been packpacking overnight) ... fatigued easily - stayed in bed all day. took ibuprofen at ~ 2am Saturday and felt a little better. by Saturday morning most of symptoms were gone - except sore kidneys. took a steam bath and that helped
Injection site upper part of left non dominant arm. Pressure at site during and after injection. Arm became overly sore hours after injection. Within a week the arm was so sore I could not lift it without pain. ADVIL/ALEVE/Ice did nothing to alleviate pain. Loss of range of motion in arm, could not put arm over head or behind back without severe pain. Many sleepless nights due to pain and no relief with OTC meds. Pain began to travel from my upper shoulder, to my elbow and down to my fingers. I had NO prior injuries before the vaccination, I have received a flu vaccine through Agency or my job for over 15 years and have never once had any illness, lasting pain like this. I feel the nurse administering the vaccination may have felt rushed during the injection and did not ask me to relax my arm, she injected me quickly while I was tending to my two children and possibly the administration of the vaccine vs the vaccine itself caused the pain and damage to my arm. 8 weeks to the day later I am still in pain. I have lost sleep, stopped exercising. Pain has improved since the vaccination but I feel it is going to take another 1-3 months before I can lift anything heavier than my purse or raise my hand/arm without flinching.
partial administration of only the adjuvant portion; partial administration of only the adjuvant portion; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 51-year-old male patient who received Herpes zoster (Shingrix) (batch number DE9L4R, expiry date 27th January 2023) for prophylaxis.   On 20th July 2021, the patient received Shingrix. On 20th July 2021, unknown after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered and inappropriate preparation of medication. On an unknown date, the outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were unknown.  Additional details provided were as follows: The reporter informed that the partial administration of only the adjuvant portion of Shingrix to the patient, which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered. The reporter consented to follow-up by email.
I began with ringing in my ears about one month after the booster dose of the vaccine. It is constant 24/7. Sounds like crickets are in my ears.
diarrhea - started about 36 hours after receiving the vaccine, about 6 or 7 episodes of very loose stools, lasting about 8-9 hours; took kaopectate, resolved within an hour of taking the kaopectate.
Redness, inflammation, feeling of warmth at the site of injection, nausea, diarrhea the morning after administration of the vaccine.
within 24 hours of the second vaccine i have felt body aches, shivers, mild fever, head ache, nauseous diarrhea
Approx. 2 in diameter of redness & soreness at the site of injection. Feeling hot & fever at a in site of injection. Took BENADRYL on 6/14/12.
This is a spontaneous report from a contactable consumer.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient got COVID-19 after first vaccination but before the second one. Event took place after use of product. Event outcome was unknown.    Information about lot/batch number has been requested.
On 2/22/2023, I woke up with a scratchy, sore throat. As the day went on, it seemed to get worse. I became hoarse. By mid-afternoon, I developed a fever of about 101. I went to bed. The next morning, I still had the sore throat and fever. I also had chills and developed a cough. I took a home antigen test and got a positive result. I called my doctor, who prescribed Paxlovid. By 2/27/2023, I was starting to feel better. My fever had either resolved or was low-grade at this point, but I still had a lot of coughing and fatigue. I tested negative for COVID-19 on about 3/2/2023, but the cough and fatigue still persisted. Towards the end of March 2023, I went to the doctor, because I still had coughing and fatigue. I was prescribed an Asmanex inhaler. This has helped, but if I don't use it, I still have a bit of a cough. I still don't feel like I have all of my stamina back from before the COVID--19, though it is getting better. I still get tired just walking around the neighborhood, though.
Received an expired shot of the Moderna; No adverse event; This spontaneous case was reported by an attorney and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received an expired shot of the Moderna) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received an expired shot of the Moderna) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received an expired shot of the Moderna) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Relevant concomitant medications were not reported.  It was reported that patient had received an expired shot of the Moderna COVID-19 vaccine.  Treatment information was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Patient reported on 12/2/02 states she had local reaction with redness 4"x2" around the injection site the night after injection. 11/25 redness getting bigger from left arm pit down to elbows by Friday 11/29/02. Patient received antibiotic Augmentin after she spoke to doctor; complaints of redness, sore and warm to touch; her left upper arm. Now patient states felt ok now after antibiotic and treatment.
Injection site redness, minor swelling, painful to touch, very hot 9:00 on 3/30/21. On 3/31/21, itchy, very red - redness circumference bigger, hot to touch, very painful at slightest touch or pressure. 4/1/21 same as 3/31. 4/2/21, still red, itchy, hurts to press on but can touch without pain and can gently scratch the itching. Seems to be getting better since I can touch and scratch the itch without it hurting. Still can?t press on it. Feels like a bad black and blue mark.
Approximately 45 minutes after the vaccine began to have dizziness, increased anxiety, and wheezing. Progressed to difficulty breathing/shortness of air and unclear thinking.  Related hypoxia occurred.  Treated at home with antihistamines and albuterol.  Epi-pen was not used, but should have been.
By the end of the day of administration, Right deltoid was very sore and formed a red rash that itched. Pt felt achy. After three weeks, slight redness in upper right arm is still present with slight itch.
fever, nausea, vomiting, severe body aches severe left arm pain, all symptoms worse that 1st dose. Fever persisted from 1/7/21 to 1/10/21. Seen in ER 1/9/21 with T 101.9 again & workup (-) for bacterial infection /sepsis , COVID neg, flu neg.
caller received his first dose of the Pfizer Covid vaccine in March and then got Covid; caller received his first dose of the Pfizer Covid vaccine in March and then got Covid; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A male patient of an unspecified age received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on Mar2021, as single dose (Batch/Lot number was not reported) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient got Covid after first dose in 2021. The patient was unsure if he should now restart the series or get the second dose. He had talked to multiple doctors and one said he can start again after waiting 3 months and another doctor said he should wait and start all over again. He stated he was still confused and didn't know what to do. Everyone was giving him different answers and it was still very very confusing. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Shingles months AFTER the vaccine / suspected vaccination failure; shingles; This case was reported by a consumer  via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included chickenpox (had chicken pox and all of the usual childhood maladies).   On an unknown date, the patient received Shingles vaccine. On an unknown date, several months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient developed a light case of Shingles several years ago a few months after having had the vaccine. So much for the prevention. However the patient guess, it could have been worse the patient not gotten the shot. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation was unknown at the time of reporting. The follow up was not required
Fatigue, headache, nausea, very sore arm, and a week later developed a red, hot, swollen, itchy rash around the injection site.  It became sore again.
Felt a little bit funny; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt a little bit funny) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DABIGATRAN ETEXILATE MESILATE (PRADAXA), AMIODARONE, CLOPIDOGREL and QUETIAPINE for an unknown indication.  On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Felt a little bit funny). At the time of the report, FEELING ABNORMAL (Felt a little bit funny) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No treatment information was provided.   This case was linked to MOD-2021-341095 (Patient Link).
pt recv vax 15MAR96 & 16MAR96 pt devel a rash on arm around inj site;pt did not feel it was necessary to see MD 17MAR96; pt recovered;
Child suffered fever after receiving MMR vaccine. Child thereafter stopped talking or saying his favorite word. Child vocal skills regressed, as did his social behavior.
This case was considered medically important (OMIC). Information regarding Prevenar (pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) injection) was received from a mother who reported that her son is autistic. The patient received the third dose on an unspecified date. Relevant medical history was not provided. Indication for Prevnar was immunization. Product was administered on an unspecified date. Dose regimen was not provided. Additional suspect medication included Hib-Titer vaccine (haemophilus B conjugate vaccine diphtheria crm197 protein conjugate) injection). Concomitant medication were not reported. a mother reported that her son is autistic (autism). The reporter commented that she does not believe that the thimerosal caused her son to be autistic. Outcome is unknown. No additional information was available at the time of this report.
Clinic sent patient to ED for lower lobe pneumonia and hypoxia.  Patient admitted to the hospital for dyspnea and pneumonia due to Covid and treated with remdesivir.
This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), MUSCULOSKELETAL STIFFNESS (Stiffness of neck), VOMITING (Vomiting), NAUSEA (Nausea) and MYALGIA (Body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), MUSCULOSKELETAL STIFFNESS (Stiffness of neck), VOMITING (Vomiting), NAUSEA (Nausea), MYALGIA (Body aches) and PYREXIA (fever). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), MUSCULOSKELETAL STIFFNESS (Stiffness of neck), NAUSEA (Nausea), MYALGIA (Body aches) and PYREXIA (fever) had resolved and VOMITING (Vomiting) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication were provided. No treatment information were provided; This case was linked to MOD-2021-096180 (E2B Linked Report).; Sender's Comments: MOD-2021-096180:Same Reporter
Fever; nausea; vomiting; diarrhea; This case was reported by a consumer via call center representative and described the occurrence of fever in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pyrexia (received 1st dose of Shingrix on 18th August 2021 (refer case US2022063383)). Concurrent medical conditions included diarrhea (sensitivity reaction (diarrhea, nausea and vomiting) from eating red meats), nausea (sensitivity reaction (diarrhea, nausea and vomiting) from eating red meats) and vomiting (sensitivity reaction (diarrhea, nausea and vomiting) from eating red meats).   On 20th October 2021, the patient received the 2nd dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced fever, nausea aggravated, vomiting aggravated and diarrhea aggravated. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the fever, nausea aggravated, vomiting aggravated and diarrhea aggravated were recovered/resolved.   It was unknown if the reporter considered the fever, nausea aggravated, vomiting aggravated and diarrhea aggravated to be related to Shingrix.     Linked case(s) involving the same patient: US2022063383   Additional Information: GSK Receipt Date: 11-APR-2022 Reporter's comment: The reporter was the patient, who called in regarding adverse reactions she had to Shingrix. The patient reported she received second dose of Shingrix and after taking vaccine she developed a similar reaction, citing nausea, vomiting and fever which lasted few days after and had since resolved.  The patient also mentioned that since receiving Shingrix, she had an increased sensitivity reaction (diarrhea, nausea and vomiting) from eating red meats.  The patient reported that this had been an issue for her since before taking the vaccine but had become markedly worse since Shingrix. She had been evaluated for a possible alpha gal allergy and did not have a diagnosis as of the reporting time.  The reporter consented to follow up. The reporter was provided information on side effects per package insert and content. Provided medical advise disclaimer.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022063383:Same patient/reporter
Lightheadedness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheadedness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (Lightheadedness). At the time of the report, DIZZINESS (Lightheadedness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Developed urticarial rash to bilateral wrists and sacrum/coccyx. Was treated with Benadryl, Zantac, Zyrtec, and 5 days of Prednisone. Rash went away. At the end of the Prednisone course rash returned. No new products the only thing identified was the Anthrax Vaccine given the day before rash. Was seen in ER given Dexamethasone. Rash improved but didn't resolve. Was given 3 week Prednisone taper. Rash resolved. Still currently taking this tx. Has referral to allergy specialist.
Within 72 hrs. of receiving the first dose of her Pfizer vaccine she developed sharp headache unlike any headaches that she has had in the past, located bilateral frontal and on top of her head. Not associated with photophobia, phonophobia, nausea, vomiting, or vision changes, but can be severe enough that she has to sit down